McLean Asset Management Corp
Source: SEC Form 13F · as of Mar 2026McLean Asset Management Corp holds 15 biotech & pharma companies tracked by BioSniper, totaling $7.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$7.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 1,441 | $1.3M |
| JNJJOHNSON & JOHNSON | 3,299 | $806K |
| ABBVAbbVie Inc. | 3,204 | $697K |
| AZNASTRAZENECA PLC | 3,418 | $674K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,951 | $528K |
| MRKMerck & Co., Inc. | 3,959 | $476K |
| MCKMcKesson Corporation | 492 | $426K |
| CORCencora Inc. | 1,346 | $423K |
| BMYBRISTOL MYERS SQUIBB CO | 6,540 | $397K |
| AMGNAMGEN INC | 1,093 | $385K |
| PMPhilip Morris International Inc | 2,071 | $342K |
| GILDGILEAD SCIENCES, INC. | 1,812 | $253K |
| PFEPFIZER INC | 8,915 | $250K |
| ABTABBOTT LABORATORIES | 2,113 | $217K |
| REGNREGENERON PHARMACEUTICALS, INC. | 272 | $210K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.